Skip to main content
  1. Home
    /
  2. IPO
    /
  3. Park Medi World Limited
Park Medi World Limited
8.05xsubscribed

Park Medi World Limited

Hospital & Healthcare Services
listed
₹14,168Min. investment

Park Medi World Limited IPO Details

SectorHospital & Healthcare Services
Price range₹154 – ₹162
IPO type
Regular
Lot size92 shares
Issue size₹920Cr
Red Herring Prospectus
Read
Market cap
₹6,997CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹1,393.5CrHigher than sector avg
Growth rate3Y CAGR
5.39%

Park Medi World Limited Subscription Status

Date
QIB
NII
Retail
Total
10-Dec-25
0.26 times (X)
0.66 times (X)
0.62 times (X)
0.53 times (X)
11-Dec-25
0.31X
1.38X
1.2X
0.99X
12-Dec-25
9.24X
15.02X
3.07X
8.05X

As on 10-Dec-25, 5:30 PM

Park Medi World Limited Timeline

  1. Pre-apply
    8 Dec 2025
  2. Bid start
    10 Dec 2025
  3. Bid end
    12 Dec 2025
  4. Allotment
    15 Dec 2025
  5. Release of funds
    16 Dec 2025
  6. Demat transfer
    16 Dec 2025
  7. Listing
    17 Dec 2025

About Park Medi World Limited

Park Medi World Limited is the second-largest private hospital chain in North India, with an aggregate capacity of 3,000 beds, and the largest in Haryana, with 1,600 beds as of March 31, 2025. The company operates 14 NABH-accredited multi-super speciality hospitals, including 8 that are also NABL-accredited, spread across Haryana, New Delhi, Punjab and Rajasthan. The company offers over 30 super speciality and speciality services, including internal medicine, neurology, urology, general surgery, gastroenterology, orthopaedics and oncology.
Established initially through a clinic in 2000, the Park Hospital brand expanded steadily with both organic additions and acquisitions. The company follows a cluster-based expansion model, leveraging proximity to improve resource sharing and operational efficiency. Acquired hospitals contributed 55.12% of revenue from operations in H1FY26, demonstrating strong integration capabilities.
It has also developed a strong clinical ecosystem comprising 1,014 doctors, 2,142 nurses, 870 ICU beds, and 67 operating theatres as of September 30, 2025. This network comprises two dedicated cancer units, linear accelerators, and iMARS robotic-assisted surgery systems installed across three hospitals, thereby facilitating advanced minimally invasive care. Five Hospitals are also approved for kidney transplants, strengthening the capability in high-acuity services.
The company offers care across both in-patient and out-patient formats, with 46,551 in-patients and 392,049 out-patients served as of H1FY26. Clinical efficiency improvements have supported a 6.35-day average length of stay, contributing to better bed utilisation and throughput.
The hospital chain benefits from a diversified speciality revenue mix, mitigating concentration risk. In H1FY26, internal medicine contributed 29.65%, Neurology 14.98%, Urology 10.85%, Cardiology 10.25% and Gastroenterology 8.63% of revenue from operations, while Oncology and Orthopaedics together contributed 11.64%. It has demonstrated strong network scaling, increasing its bed capacity from 2,550 beds as of March 31, 2023 to 3,250 beds as of September 30, 2025, a 27.45% expansion within two years.
North India’s healthcare market is forecast to grow at 12% to 14% CAGR to ₹33,00,000 crore-₹34,00,000 crore by FY29, contributing around 1/3rd of India’s healthcare delivery sector. However, with a population of 42.9 crore supported by only 620,000–630,000 beds, the region faces a structural shortfall of over 227,536 beds versus the National Health Policy norm of 20 beds per 10,000 population. Park Medi World, already the largest hospital chain in Haryana and a leading player in North India, is well-positioned to benefit from this gap with 1,650 beds added through eight acquisitions and a strong, under-execution pipeline across Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur, enabling disciplined scale-up in high-demand clusters.
The company’s focus remains on expanding its hospital network, scaling its operations and improving operational efficiencies and retaining and attracting skilled and experienced doctors and clinicians.
Now, Park Medi World Innovations Ltd is launching its initial public offering (IPO), which consists of a fresh issue of ₹770 crore and an offer for sale of ₹150 crore. The total issue size of the IPO is ₹920 crore. Its shares will be listed on the NSE and BSE.

How to pre-apply for the Park Medi World Limited IPO?

You can pre-apply for the Park Medi World Limited IPO on Upstox. The pre-application for this IPO, which means pre-apply open date, usually begins a day before the IPO opens for subscription.
Follow these steps to pre-apply for the IPO:
  • Login to your Upstox account, using your six-digit PIN
  • After successfully logging in, click on ‘Discover’
  • On the Discover tab, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, look for the ‘Park Medi World Limited IPO’ tab and click on it
  • Now fill in all the required information, like ‘bid price’ and ‘lot size’
  • Confirm and click on ‘Pre-Apply’
  • Accept the mandate on your UPI app

How to apply for the Park Medi World Limited IPO?

If you are interested in this investment opportunity but unsure how to apply for the Park Medi World Limited IPO, here we are listing out the steps for you.
Here’s a step-by-step guide on how to apply for the Park Medi World Limited IPO on Upstox:
  • Login to your Upstox account, using your six-digit PIN
  • After successfully logging in, click on ‘Discover’
  • On the Discover tab, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, look for the Park Medi World Limited IPO’ tab and click on it
  • Now fill in all the required information, like ‘bid price’ and ‘lot size’
  • Confirm and click on ‘Apply’
  • Accept the mandate on your UPI app

How to check the Park Medi World Limited IPO allotment status?

When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally done around five to seven days after an IPO closes. This is also true in the case of the Park Medi World Limited IPO.
The Park Medi World Limited IPO’s closing date is 31 October 2022. The Park Medi World Limited IPO’s allotment date has been set seven days later, on 7 November 2022.
Here’s a step-by-step guide on how to check the Park Medi World Limited IPO allotment status:
  • Login to your Upstox account, using your six-digit PIN
  • After successfully logging in, click on ‘Discover’
  • On the Discover page, you will find the ‘Invest in IPO’ section
  • Under the Invest in IPO section, you will find the ‘View all’ option
  • Once you click on ‘View all’, you will be directed to the ‘IPO’ tab
  • In the ‘IPO’ tab, click on ‘My applications’
  • In ‘My applications’, under the History section, your allotment status will be mentioned.

Park Medi World Limited IPO Analysis

IPO REVIEW

Park Medi World Limited | Analysis Video

Should you apply?

Watch our analysts break down the Park Medi World Limited IPO — business model, financials, valuation and key risks — to help you decide whether to apply. The video covers the IPO price band, important dates, and what the subscription numbers mean for retail investors.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Strength and Weakness

Market leadership in North India

The company is the second-largest private hospital chain in North India, with 3,250 beds as of September 30, 2025, including 870 ICU beds and 67 OTs, and the largest in Haryana with 1,600 beds. Its 14 NABH-accredited hospitals are strategically located across Delhi, Haryana, Punjab, and Rajasthan, benefiting from a cluster-based expansion model that enhances brand recall and operational synergies.

High-quality, affordable care

The company addresses the mass-market demand for healthcare, which is driven by middle-class patients, ensuring affordability with the usage of advanced technologies such as robotic iMARS surgical systems. Strong speciality mix with 30+ super-specialities limits concentration risk; Internal Medicine comprised 29.65% of revenue, Neurology 14.98%, and Urology 10.85%, as of H1FY26.

Demonstrated acquisition and integration

With 8 successful acquisitions, including Grecian Mohali and Healing Touch Ambala, Park Medi World has added 1,650 beds. The acquisitions contributed 55.12% of revenue and 61.90% to PAT in H1FY26 with strong turnaround capabilities, demonstrating scalable SOP-driven integration. Further, it is also expanding its presence into Uttar Pradesh through the Kanpur hospital acquisition.

Asset-ownership model

With 10 out of 14 hospitals owned, the company enjoys benefits from lower overheads and stronger control over quality and cash flows. Indeed, its gross block per bed of ₹0.34 crore was the lowest amongst peers in FY25 versus an industry average of ₹1.06 crore, thereby commanding superior capital efficiency and reinvestment capacity.

Objectives of Park Medi World Limited IPO

Repayment of borrowings
49.30%
The company will use ₹380 crore towards pre-payment in full or part of certain borrowings
General corporate purposes
39.20%
Part of the IPO proceeds will be used for general corporate purposes and unidentified acquisitions.
Development of new hospitals
7.80%
The company will use ₹ 60.5 crore to develop a new hospital under subsidiary Park Medicity (NCR).
Purchase of medical equipment
3.50%
The company will use ₹ 27.46 crore for purchase of medical equipment by itself and its subsidiaries.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹1,393.5Cr5.39%₹213.2Cr₹6,997Cr29.190.61
This sector (avg.)₹810.55Cr---₹87.66Cr₹10,075.9Cr55.140.40
₹21,794Cr---₹1,472.1Cr₹1,00,081.3Cr59.860.96
₹7,028.46Cr---₹1,075.88Cr₹93,096.78Cr68.940.32
₹7,782.75Cr---₹809.39Cr₹64,284.69Cr63.430.28

*Revenue for financial year 2024-25. Lower P/E and D/E ratios are generally preferred.

Park Medi World Limited Contact Details

Company NamePark Medi World Limited

How to apply for Park Medi World Limited?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Park Medi World Limited IPO FAQs

Investors can apply for the Park Medi World Limited through their Demat account via the stock exchange or through their broker.
The issue size of the Park Medi World Limited is 920 Cr.
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Park Medi World Limited will be open between 2025-12-10 and 2025-12-12.
Park Medi World Limited allotment date is 2025-12-16. For Park Medi World Limited allotment status check, you can visit the website of the registrar of the IPO.
For Park Medi World Limited, the IPO registrar is Kfin Technologies Limited. You can check Park Medi World Limited allotment status on the website of the registrar.
The shares are proposed to be listed on the BSE and NSE.
The Park Medi World Limited shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.
The Park Medi World Limited lot size is 92 and minimum order quantity is 92.
Park Medi World Limited has set the price band for its IPO at 162 per equity share with a face value of 2.